1. Farewell to Prof. Dr. Hugo A. Katus, Co-editor-in-chief of Clinical Research in Cardiology

   • Norbert Frey
   • Michael Böhm

   Editorial 15 February 2023 Pages: 333 - 333

   

2. Native T1 mapping for the diagnosis of cardiac amyloidosis in patients with left ventricular hypertrophy

   • Daniel Lavall
   • Nicola H. Vosshage
   • Ulrich Laufs

   Original Paper Open access 31 March 2022 Pages: 334 - 342

   

3. High prevalence of reduced fertility and use of assisted reproductive technology in a German cohort of patients with peripartum cardiomyopathy

   • Tobias J. Pfeffer
   • Manuel List
   • Denise Hilfiker-Kleiner

   Original Paper Open access 13 May 2022 Pages: 343 - 352

   

4. Therapeutic value of tafamidis in patients with wild-type transthyretin amyloidosis (ATTRwt) with cardiomyopathy based on cardiovascular magnetic resonance (CMR) imaging

   • Bishwas Chamling
   • Michael Bietenbeck
   • Ali Yilmaz

   Original Paper Open access 06 June 2022 Pages: 353 - 362

   

5. Towards automatic classification of cardiovascular magnetic resonance Task Force Criteria for diagnosis of arrhythmogenic right ventricular cardiomyopathy

   • Mimount Bourfiss
   • Jörg Sander
   • Birgitta K. Velthuis

   Original Paper Open access 06 September 2022 Pages: 363 - 378

   

6. Effectiveness of implantable loop recorder and Holter electrocardiographic monitoring for the detection of arrhythmias in patients with peripartum cardiomyopathy

   • Julian Hoevelmann
   • Karen Sliwa
   • Charle Viljoen

   Original Paper Open access 22 September 2022 Pages: 379 - 391

   

7. Cardiac magnetic resonance abnormalities in patients with acute myocarditis proven by septal endomyocardial biopsy

   • Giovanni Peretto
   • Marco Merlo
   • Patrizia Pedrotti

   Original Paper 16 September 2022 Pages: 392 - 400

   

8. Epidemiology of cardiac amyloidosis in Germany: a retrospective analysis from 2009 to 2018

   • Svenja Ney
   • Peter Ihle
   • Roman Pfister

   Original Paper Open access 14 October 2022 Pages: 401 - 408

   

9. The predictive value of high sensitivity troponin measurements in patients treated with immune checkpoint inhibitors

   • Barliz Waissengein
   • Bian Abu Ata
   • Michal Laufer-Perl

   Original Paper 27 October 2022 Pages: 409 - 418

   

10. Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications

    • Vincenzo Nuzzi
    • Antonio Cannatà
    • Gianfranco Sinagra

    Original Paper Open access 17 November 2022 Pages: 419 - 430

    

11. Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination

    • Constantin Schwab
    • Lisa Maria Domke
    • Peter Schirmacher

    Original Paper Open access 27 November 2022 Pages: 431 - 440

    

12. Supra-normal left ventricular ejection fraction in cardiac amyloidosis

    • Pieter Martens
    • Mazen Hanna
    • W. H. Wilson Tang

    Letter to the Editors 31 May 2022 Pages: 441 - 443

    

13. Cardiac transthyretin/leukocyte chemotactic factor (LECT) 2 double amyloidosis in a patient suffering from heart failure

    • Simon Greulich
    • Heiko Mahrholdt
    • Karin Klingel

    Letter to the Editors 04 August 2022 Pages: 444 - 449

    

14. Imaging modalities in early cardiac transthyretin amyloidosis: who is first?

    • Svenja Ney
    • Lenhard Pennig
    • Roman Pfister

    Letter to the Editors Open access 19 July 2022 Pages: 450 - 453

    

15. Correction: Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications

    • Vincenzo Nuzzi
    • Antonio Cannatà
    • Gianfranco Sinagra

    Correction Open access 06 December 2022 Pages: 454 - 454